Registration

Opening Remarks

(RECORDING)

H.E. Mr Jürg Burri, Ambasador of Switzerland to Poland (10′)

Anna Goławska, Undersecretary of State, Ministry of Health  (10′)

Michał Stępień, President of the Polish-Swiss Chamber of Commerce (10′)

Keynote Speeches: What are the success factors for innovation in pharma and life sciences in Poland and Switzerland, respectively?

Piotr Arak, Director of the Polish Economic Institute (15′) (RECORDING)

Neil Goldsmith, Director Strategy, BaseLaunch (15′) (RECORDING)

Dr Piotr Dardziński, President of Łukasiewicz Research Network (15′) (RECORDING)

Input I: How does Switzerland manage to connect scientists and entrepreneurs to launch and grow biotech companies?

Jordi Montserrat, Co-Founder and Managing Partner of Venturelab (15′) (RECORDING)

Input II: Building Biotechs – Corporate Venture Capital & Founder/Management Perspectives

(RECORDING)

Bart Dzikowski, Managing Director, Head of Transactions & Legal of Novartis Venture Fund; board member at UZH Life Sciences Fund, Oculis S.A. and Enterprise Therapeutics

Dr Michał Walczak, Co-Founder and Chief Scientific Officer, Captor Therapeutics

Input III: Personal observations about Poland’s potential from a Swiss expert’s perspective

Dr Liliane Brunner Halbach, Global Pharma and Life Sciences Expert (15′)

Coffe break

Panel discussion: How to create an environment conducive to successful R&D in pharma and life sciences

(RECORDING)

Irma Veberič, General Manager Roche Poland

Dr Radosław Sierpiński, Head of Poland’s Medical Research Agency

Jan Krzewiński, President of Polpharma Biologics Gdańsk

Prof. Jacek Jemielity, bio-organic chemistry, University of Warsaw

Dr hab. Michał Wszola,  CEO of Polbionica Ltd., surgeon transplantologist

Dr Agnieszka Sznyk, Innowo (moderator)

Wrapping Up & Conclusions

Dr inż. Agnieszka Sznyk, Innowo (moderator)